KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Common Equity (2016 - 2025)

Historic Common Equity for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $51.9 billion.

  • Merck's Common Equity rose 1648.79% to $51.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $51.9 billion, marking a year-over-year increase of 1648.79%. This contributed to the annual value of $46.4 billion for FY2024, which is 2321.51% up from last year.
  • According to the latest figures from Q3 2025, Merck's Common Equity is $51.9 billion, which was up 1648.79% from $49.1 billion recorded in Q2 2025.
  • Merck's Common Equity's 5-year high stood at $51.9 billion during Q3 2025, with a 5-year trough of $27.0 billion in Q1 2021.
  • Its 5-year average for Common Equity is $42.0 billion, with a median of $43.3 billion in 2022.
  • As far as peak fluctuations go, Merck's Common Equity surged by 5145.9% in 2022, and later tumbled by 1828.78% in 2023.
  • Merck's Common Equity (Quarter) stood at $38.3 billion in 2021, then grew by 20.39% to $46.1 billion in 2022, then dropped by 18.29% to $37.6 billion in 2023, then increased by 23.22% to $46.4 billion in 2024, then grew by 11.94% to $51.9 billion in 2025.
  • Its last three reported values are $51.9 billion in Q3 2025, $49.1 billion for Q2 2025, and $48.4 billion during Q1 2025.